KRYS logo

Krystal Biotech (KRYS) Cash From Financing

Annual CFF

$27.01 M
-$175.74 M-86.68%

December 31, 2024


Summary


Performance

KRYS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYScash flowmetrics:

Quarterly CFF

$2.43 M
-$937.00 K-27.85%

December 31, 2024


Summary


Performance

KRYS Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYScash flowmetrics:

TTM CFF

$27.01 M
-$191.00 K-0.70%

December 31, 2024


Summary


Performance

KRYS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYScash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

KRYS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-86.7%-77.1%-87.3%
3 y3 years-92.2%-20.9%-23.6%
5 y5 years-74.9%-20.9%-23.6%

KRYS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.2%at low-98.8%+548.0%-92.2%at low
5 y5-year-92.2%at low-98.8%+548.0%-92.2%at low
alltimeall time-92.2%+731.5%-98.8%+450.4%-92.2%+8904.7%

Krystal Biotech Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$27.01 M(-86.7%)
$2.43 M(-27.8%)
$27.01 M(-0.7%)
Sep 2024
-
$3.37 M(-68.4%)
$27.20 M(-26.9%)
Jun 2024
-
$10.64 M(+0.5%)
$37.23 M(-82.4%)
Mar 2024
-
$10.58 M(+304.1%)
$211.86 M(+4.5%)
Dec 2023
$202.75 M(+473.6%)
$2.62 M(-80.4%)
$202.75 M(-0.2%)
Sep 2023
-
$13.39 M(-92.8%)
$203.20 M(+5.9%)
Jun 2023
-
$185.27 M(>+9900.0%)
$191.93 M(+413.7%)
Mar 2023
-
$1.47 M(-52.0%)
$37.36 M(+5.7%)
Dec 2022
$35.35 M(-89.8%)
$3.07 M(+44.8%)
$35.35 M(-84.9%)
Sep 2022
-
$2.12 M(-93.1%)
$234.35 M(+0.3%)
Jun 2022
-
$30.70 M(-5764.2%)
$233.74 M(+15.2%)
Mar 2022
-
-$542.00 K(-100.3%)
$202.84 M(-41.7%)
Dec 2021
$347.69 M(+194.6%)
$202.07 M(>+9900.0%)
$347.69 M(+138.5%)
Sep 2021
-
$1.51 M(-857.8%)
$145.75 M(+0.9%)
Jun 2021
-
-$199.00 K(-100.1%)
$144.41 M(-44.9%)
Mar 2021
-
$144.30 M(>+9900.0%)
$262.08 M(+122.1%)
DateAnnualQuarterlyTTM
Dec 2020
$118.02 M(+9.8%)
$141.00 K(-15.1%)
$118.02 M(-0.1%)
Sep 2020
-
$166.00 K(-99.9%)
$118.18 M(-9.9%)
Jun 2020
-
$117.47 M(>+9900.0%)
$131.18 M(+21.8%)
Mar 2020
-
$243.00 K(-18.7%)
$107.73 M(+0.2%)
Dec 2019
$107.53 M(+45.6%)
$299.00 K(-97.7%)
$107.53 M(-37.3%)
Sep 2019
-
$13.17 M(-86.0%)
$171.51 M(+2.2%)
Jun 2019
-
$94.02 M(>+9900.0%)
$167.90 M(+127.3%)
Mar 2019
-
$40.00 K(-99.9%)
$73.88 M(+0.0%)
Dec 2018
$73.85 M(+42.6%)
$64.29 M(+573.2%)
$73.85 M(+732.9%)
Sep 2018
-
$9.55 M(>+9900.0%)
$8.87 M(-82.1%)
Jun 2018
-
$4000.00(-33.3%)
$49.48 M(-3.9%)
Mar 2018
-
$6000.00(-100.9%)
$51.47 M(-0.6%)
Dec 2017
$51.77 M(+1493.4%)
-$693.00 K(-101.4%)
$51.77 M(-1.3%)
Sep 2017
-
$50.16 M(+2409.4%)
$52.46 M(+2181.9%)
Jun 2017
-
$2.00 M(+566.3%)
$2.30 M(+666.3%)
Mar 2017
-
$300.00 K
$300.00 K
Dec 2016
$3.25 M
-
-

FAQ

  • What is Krystal Biotech annual cash flow from financing activities?
  • What is the all time high annual CFF for Krystal Biotech?
  • What is Krystal Biotech annual CFF year-on-year change?
  • What is Krystal Biotech quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Krystal Biotech?
  • What is Krystal Biotech quarterly CFF year-on-year change?
  • What is Krystal Biotech TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Krystal Biotech?
  • What is Krystal Biotech TTM CFF year-on-year change?

What is Krystal Biotech annual cash flow from financing activities?

The current annual CFF of KRYS is $27.01 M

What is the all time high annual CFF for Krystal Biotech?

Krystal Biotech all-time high annual cash flow from financing activities is $347.69 M

What is Krystal Biotech annual CFF year-on-year change?

Over the past year, KRYS annual cash flow from financing activities has changed by -$175.74 M (-86.68%)

What is Krystal Biotech quarterly cash flow from financing activities?

The current quarterly CFF of KRYS is $2.43 M

What is the all time high quarterly CFF for Krystal Biotech?

Krystal Biotech all-time high quarterly cash flow from financing activities is $202.07 M

What is Krystal Biotech quarterly CFF year-on-year change?

Over the past year, KRYS quarterly cash flow from financing activities has changed by -$8.15 M (-77.06%)

What is Krystal Biotech TTM cash flow from financing activities?

The current TTM CFF of KRYS is $27.01 M

What is the all time high TTM CFF for Krystal Biotech?

Krystal Biotech all-time high TTM cash flow from financing activities is $347.69 M

What is Krystal Biotech TTM CFF year-on-year change?

Over the past year, KRYS TTM cash flow from financing activities has changed by -$184.84 M (-87.25%)